{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:11:00Z","timestamp":1776816660213,"version":"3.51.2"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.jsat.2011.05.005","type":"journal-article","created":{"date-parts":[[2011,8,7]],"date-time":"2011-08-07T10:50:04Z","timestamp":1312714204000},"page":"374-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment"],"prefix":"10.1016","volume":"41","author":[{"given":"Traci R.","family":"Rieckmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne E.","family":"Kovas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bentson H.","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda J.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2011.05.005_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/B:MHSR.0000024351.12294.65","article-title":"Mental health provider attitudes toward adoption of evidence-based practice: The Evidence-Based Practice Attitude Scale (EBPAS)","volume":"6","author":"Aarons","year":"2004","journal-title":"Mental Health Services Research"},{"key":"10.1016\/j.jsat.2011.05.005_bb0010","doi-asserted-by":"crossref","first-page":"628","DOI":"10.15288\/jsad.2009.70.628","article-title":"Counselor attitudes toward pharmacotherapies for alcohol dependence","volume":"70","author":"Abraham","year":"2009","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.jsat.2011.05.005_bb0015","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF02287509","article-title":"Managed care and technical efficiency in outpatient substance abuse treatment units","volume":"25","author":"Alexander","year":"1998","journal-title":"The Journal of Behavioral Health Services & Research"},{"key":"10.1016\/j.jsat.2011.05.005_bb0020","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/10550490490440807","article-title":"Bringing buprenorphine\u2013naloxone detoxification to community treatment providers: The NIDA Clinical Trials Network field experience","volume":"13","author":"Amass","year":"2004","journal-title":"The American Journal of Addictions"},{"key":"10.1016\/j.jsat.2011.05.005_bb0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.drugalcdep.2003.11.002","article-title":"Effectiveness of interventions on opiate withdrawal treatment: An overview of systematic reviews","volume":"73","author":"Amato","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2011.05.005_bb0030","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1176\/ajp.156.11.1758","article-title":"Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: Results of a placebo-controlled trial","volume":"156","author":"Anton","year":"1999","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2011.05.005_bb0035","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1360-0443.2001.9656834.x","article-title":"A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence","volume":"96","author":"Barnett","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2011.05.005_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jsat.2007.01.005","article-title":"Counselor assessments of training and adoption barriers","volume":"33","author":"Bartholomew","year":"2007","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2011.05.005_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugalcdep.2009.03.020","article-title":"Comparing overdose mortality associated with methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2011.05.005_bb0050","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/10550880903028452","article-title":"Non-medical use of prescription analgesics: A three-year national longitudinal study","volume":"28","author":"Boyd","year":"2009","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2011.05.005_bb0055","series-title":"Hierarchical linear models: Applications and data analysis methods","author":"Bryk","year":"2002"},{"key":"10.1016\/j.jsat.2011.05.005_bb0060","series-title":"Medication-assisted treatment for opioid addiction in opioid treatment programs","author":"Center for Substance Abuse Treatment","year":"2005"},{"key":"10.1016\/j.jsat.2011.05.005_bb0065","series-title":"Buprenorphine: A guide for nurses","author":"Center for Substance Abuse Treatment","year":"2009"},{"key":"10.1016\/j.jsat.2011.05.005_bb0070","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMsb1002320","article-title":"Accountability measures\u2014Using measurement to promote quality improvement","volume":"363","author":"Chassin","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2011.05.005_bb0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11414-007-9069-z","article-title":"Does state certification or licensure influence outpatient substance abuse treatment program practices?","volume":"34","author":"Chriqui","year":"2007","journal-title":"Journal of Behavioral Health Services and Research"},{"key":"10.1016\/j.jsat.2011.05.005_bb0080","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","article-title":"Major increases in opioid analgesic abuse in the United States: Concerns and strategies","volume":"81","author":"Compton","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2011.05.005_bb0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10488-008-0198-3","article-title":"Barriers to adoption of new treatments: An Internet study of practicing community psychotherapists","volume":"36","author":"Cook","year":"2009","journal-title":"Administration and Policy in Mental Health"},{"key":"10.1016\/j.jsat.2011.05.005_bb0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1037\/a0013636","article-title":"Addressing the intersecting problems of opioid misuse and chronic pain treatment","volume":"16","author":"Denisco","year":"2008","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2011.05.005_bb0095","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2006.05.021","article-title":"Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials Network","volume":"32","author":"Ducharme","year":"2007","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2011.05.005_bb0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsat.2008.09.003","article-title":"Opioid treatment programs in the Clinical Trials Network: Representativeness and buprenorphine adoption","volume":"37","author":"Ducharme","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2011.05.005_bb0105","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s11606-010-1377-y","article-title":"The Physician Clinical Support System-Buprenorphine (PCSS-B): A novel project to expand\/improve buprenorphine treatment","volume":"25","author":"Egan","year":"2010","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jsat.2011.05.005_bb0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1081\/ADA-120002972","article-title":"Treatment of heroin dependence with buprenorphine in primary care","volume":"28","author":"Fiellin","year":"2002","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2011.05.005_bb0115","series-title":"Implementation research: A synthesis of the literature","author":"Fixsen","year":"2005"},{"key":"10.1016\/j.jsat.2011.05.005_bb0120","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11414-009-9169-z","article-title":"Top manager effects on buprenorphine adoption in outpatient substance abuse treatment programs","volume":"37","author":"Friedmann","year":"2010","journal-title":"The Journal of Behavioral Health Services & Research"},{"key":"10.1016\/j.jsat.2011.05.005_bb0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jsat.2005.02.003","article-title":"Adoption of naltrexone to treat alcohol dependence","volume":"28","author":"Fuller","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2011.05.005_bb0130","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jsat.2008.08.004","article-title":"Research on the diffusion of evidence-based treatments within substance abuse treatment: A systematic review","volume":"36","author":"Garner","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2011.05.005_bb0135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s10488-007-0148-5","article-title":"Assessing the organizational social context (OSC) of mental health services: Implications for research and practice","volume":"35","author":"Glisson","year":"2008","journal-title":"Administration and Policy in Mental Health"},{"key":"10.1016\/j.jsat.2011.05.005_bb0140","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.2008.802","article-title":"Patterns of abuse among unintentional pharmaceutical overdose fatalities","volume":"300","author":"Hall","year":"2008","journal-title":"Journal of American Medical Association"},{"key":"10.1016\/j.jsat.2011.05.005_bb0145","first-page":"9","article-title":"Organizational and financial issues in the delivery of substance abuse treatment services","volume":"15","author":"Horgan","year":"2001","journal-title":"Recent Developments in Alcoholism"},{"key":"10.1016\/j.jsat.2011.05.005_bb0150","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2011.05.005_bb0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0376-8716(95)01186-2","article-title":"A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence","volume":"40","author":"Johnson","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2011.05.005_bb0160","series-title":"Monitoring the Future national survey results on drug use, 1975\u20132006: Volume I, secondary school students. NIH publication no. 07-6205","author":"Johnston","year":"2007"},{"key":"10.1016\/j.jsat.2011.05.005_bb0165","unstructured":"Joint Commission. (2010). Facts about behavioral health care accreditation. http:\/\/www.jointcommission.org\/assets\/1\/18\/Behavioral_Health_Care_Accreditation.pdf Oakbrook Terrace, IL: Joint Commission."},{"key":"10.1016\/j.jsat.2011.05.005_bb0170","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","article-title":"1-Year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: A randomized, placebo-controlled trial","volume":"361","author":"Kakko","year":"2003","journal-title":"The Lancet"},{"key":"10.1016\/j.jsat.2011.05.005_bb0175","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1081\/JA-100102626","article-title":"A self-administered instrument for assessing therapeutic approaches of drug-user treatment counselors","volume":"36","author":"Kasarabada","year":"2001","journal-title":"Substance Use and Misuse"},{"key":"10.1016\/j.jsat.2011.05.005_bb0180","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2648.2008.04864.x","article-title":"The need for systems change: Reflections on knowledge translation and organizational change","volume":"65","author":"Kitson","year":"2009","journal-title":"Journal of Advanced Nursing"},{"key":"10.1016\/j.jsat.2011.05.005_bb0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jsat.2008.12.004","article-title":"Buprenorphine adoption in the National Drug Abuse Clinical Trials Network","volume":"37","author":"Knudsen","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2011.05.005_bb0190","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drugalcdep.2006.08.013","article-title":"The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clusters","volume":"87","author":"Knudsen","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2011.05.005_bb0195","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jsat.2006.03.013","article-title":"Early adoption of buprenorphine in substance abuse treatment centers: Data from the private and public sectors","volume":"30","author":"Knudsen","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2011.05.005_bb0200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drugalcdep.2006.08.013","article-title":"The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clusters","volume":"87","author":"Knudsen","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2011.05.005_bb0205","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsat.2005.05.002","article-title":"Buprenorphine diffusion: The attitudes of substance abuse treatment counselors","volume":"29","author":"Knudsen","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2011.05.005_bb0210","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/10550490701525418","article-title":"Research network involvement and addiction treatment center staff: Counselor attitudes toward buprenorphine","volume":"16","author":"Knudsen","year":"2007","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2011.05.005_bb0215","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.drugalcdep.2005.12.005","article-title":"Characteristics of U.S. substance abuse treatment facilities adopting buprenorphine in its initial stage of availability","volume":"83","author":"Koch","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2011.05.005_bb0220","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2011.05.005_bb0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/09595230020029419","article-title":"New trends in opiate pharmacotherapy","volume":"20","author":"Ling","year":"2001","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2011.05.005_bb0230","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1360-0443.2005.01154.x","article-title":"A multi-center randomized trial of buprenorphine\u2013naloxone versus clonidine for opioid detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network","volume":"100","author":"Ling","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2011.05.005_bb0235","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.evalprogplan.2011.02.002","article-title":"Community based addiction treatment staff attitudes about the usefulness of evidence-based addiction treatment and CBO organizational linkages to research institutions","volume":"34","author":"Lundgren","year":"2001","journal-title":"Evaluation and Program Planning"},{"key":"10.1016\/j.jsat.2011.05.005_bb0240","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.drugalcdep.2008.07.018","article-title":"Alcohol and opioid dependence medications: Prescription trends overall and by physician activity","volume":"99","author":"Mark","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2011.05.005_bb0245","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1521-0391.2003.tb00543.x","article-title":"Barriers to the use of medications to treat alcoholism","volume":"12","author":"Mark","year":"2003","journal-title":"The American Journal of Addiction"},{"key":"10.1016\/j.jsat.2011.05.005_bb0250","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0376-8716(00)00162-9","article-title":"The economic costs of heroin addiction in the United States","volume":"61","author":"Mark","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2011.05.005_bb0255","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0740-5472(03)00247-2","article-title":"Training rural practitioners to use buprenorphine: Using the change book to facilitate technology transfer","volume":"26","author":"McCarty","year":"2004","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2011.05.005_bb0260","first-page":"68","article-title":"Office-based treatment of opiate-dependent patients with buprenorphine: It's about time","volume":"13","author":"McDowell","year":"2006","journal-title":"Primary Psychiatry"},{"key":"10.1016\/j.jsat.2011.05.005_bb0265","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jsat.2004.03.003","article-title":"A survey of clinical practices and readiness to adopt evidence-based practices: Dissemination research in an addiction treatment system","volume":"26","author":"McGovern","year":"2004","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2011.05.005_bb0270","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5055\/jom.2009.0024","article-title":"Overcoming obstacles to implementing methadone maintenance therapy for prisoners: Implications for policy and practice","volume":"5","author":"McKenzie","year":"2009","journal-title":"Journal of Opioid Management"},{"key":"10.1016\/j.jsat.2011.05.005_bb0275","first-page":"1634","article-title":"Naltrexone and cue exposure with coping and communication skills training for alcoholics: Treatment process and 1-year outcomes","volume":"25","author":"Monti","year":"2001","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.jsat.2011.05.005_bb0280","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.280.22.1936","article-title":"Effective medical treatment of opiate addiction","volume":"280","author":"National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction","year":"1998","journal-title":"Journal of American Medical Association"},{"key":"10.1016\/j.jsat.2011.05.005_bb0285","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jsat.2008.06.006","article-title":"Factors affecting willingness to provide buprenorphine treatment","volume":"36","author":"Netherland","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2011.05.005_bb0290","series-title":"Emergency department visits involving nonmedical use of selected pharmaceuticals. No. 23)","author":"Novak","year":"2006"},{"key":"10.1016\/j.jsat.2011.05.005_bb0295","doi-asserted-by":"crossref","first-page":"852","DOI":"10.15288\/jsad.2007.68.852","article-title":"Organizational-level predictors of adoption across time: Naltrexone in private substance-use disorders treatment centers","volume":"68","author":"Oser","year":"2007","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.jsat.2011.05.005_bb0300","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jclp.20376","article-title":"Barriers and facilitators of evidence-based practice perceived by behavioral science health professionals","volume":"63","author":"Pagoto","year":"2007","journal-title":"Journal of Clinical Psychology"},{"key":"10.1016\/j.jsat.2011.05.005_bb0420","series-title":"HLM 6.08 (computer software)","author":"Raudenbush","year":"2004"},{"key":"10.1016\/j.jsat.2011.05.005_bb0305","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsat.2008.09.007","article-title":"Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence","volume":"37","author":"Ridge","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2011.05.005_bb0310","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jsat.2006.09.002","article-title":"Client and counselor attitudes toward the use of medications for treatment of opioid dependence","volume":"32","author":"Rieckmann","year":"2007","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2011.05.005_bb0315","series-title":"Diffusion of innovations","first-page":"423","year":"2003"},{"key":"10.1016\/j.jsat.2011.05.005_bb0320","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1377\/hlthaff.24.4.1005","article-title":"An agenda to combat substance abuse","volume":"24","author":"Schroeder","year":"2005","journal-title":"Health Affairs"},{"key":"10.1016\/j.jsat.2011.05.005_bb0325","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/10550490802268835","article-title":"Attitudes toward buprenorphine and methadone among opioid-dependent individuals","volume":"17","author":"Schwartz","year":"2008","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.jsat.2011.05.005_bb0330","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jsat.2006.12.023","article-title":"Moving innovations into treatment: A stage-based approach to program change","volume":"33","author":"Simpson","year":"2007","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2011.05.005_bb0335","series-title":"Multilevel analysis: An introduction to basic and advanced multilevel modeling","author":"Snijders","year":"1999"},{"key":"10.1016\/j.jsat.2011.05.005_bb0340","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1525-1497.2005.0228.x","article-title":"Buprenorphine retention in primary care","volume":"20","author":"Stein","year":"2005","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jsat.2011.05.005_bb0345","series-title":"National Household Survey on Drug Abuse: Main findings 1998","author":"Substance Abuse and Mental Health Services Administration","year":"2000"},{"key":"10.1016\/j.jsat.2011.05.005_bb0350","series-title":"Results from the 2008 National Survey on Drug Use and Health: National findings (office of applied studies, NSDUH series H-36, HHS publication no. SMA 09-4434)","author":"Substance Abuse and Mental Health Services Administration","year":"2009"},{"key":"10.1016\/j.jsat.2011.05.005_bb0355","series-title":"Heroin and other opiate admissions to substance abuse treatment: The TEDS report","author":"Substance Abuse and Mental Health Services Administration, Office of Applied Studies","year":"2009"},{"key":"10.1016\/j.jsat.2011.05.005_bb0360","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.drugalcdep.2004.12.008","article-title":"The practice of office-based buprenorphine treatment of opioid dependence: Is it associated with new patients entering into treatment?","volume":"79","author":"Sullivan","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2011.05.005_bb0365","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1176\/ps.2008.59.8.909","article-title":"Use of buprenorphine for addiction treatment perspectives of addiction specialists and general psychiatrists","volume":"59","author":"Thomas","year":"2008","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jsat.2011.05.005_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0740-5472(02)00319-7","article-title":"Research to practice: Adoption of naltrexone in alcoholism treatment","volume":"24","author":"Thomas","year":"2003","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2011.05.005_bb0375","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/alcalc\/agl100","article-title":"Knowledge and attitudes about pharmacotherapy for alcoholism: A survey of counselors and administrators in community-based addiction treatment centres","volume":"42","author":"Thomas","year":"2007","journal-title":"Alcohol and Alcoholism"},{"key":"10.1016\/j.jsat.2011.05.005_bb0380","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jsat.2010.08.005","article-title":"Advancing performance measures for use of medications in substance abuse treatment","volume":"40","author":"Thomas","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"Suppl 1","key":"10.1016\/j.jsat.2011.05.005_bb0385","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1097\/QAI.0b013e31820a820f","article-title":"Hepatic safety and lack of antiretroviral interactions with buprenorphine\/naloxone in HIV-infected opioid-dependent patients","volume":"56","author":"Vergara-Rodriguez","year":"2011","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.jsat.2011.05.005_bb0390","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11414-008-9132-4","article-title":"Substance abuse treatment organizations as mediators of social policy: Slowing the adoption of a congressionally approved medication","volume":"37","author":"Wallack","year":"2010","journal-title":"Journal of Behavioral Health Services & Research"},{"key":"10.1016\/j.jsat.2011.05.005_bb0395","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s11606-008-0686-x","article-title":"Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers","volume":"23","author":"Walley","year":"2008","journal-title":"Journal of General Internal Medicine"},{"issue":"Suppl 1","key":"10.1016\/j.jsat.2011.05.005_bb0400","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/QAI.0b013e31820a8226","article-title":"Integration of buprenorphine\/naloxone treatment into HIV clinical care: Lessons from the BHIVES collaborative","volume":"56","author":"Weiss","year":"2011","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.jsat.2011.05.005_bb0405","series-title":"The varieties of recovery experience","author":"White","year":"2005"},{"key":"10.1016\/j.jsat.2011.05.005_bb0410","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.drugalcdep.2008.06.016","article-title":"Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine\u2013naloxone and clonidine in the NIDA Clinical Trials Network drug and alcohol dependence","volume":"99","author":"Ziedonis","year":"2009","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547211001097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547211001097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:35:27Z","timestamp":1760038527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547211001097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0740547211001097"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2011.05.005","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2011.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}